Clinical trial
Effectiveness and Adverse-effect Switch Evaluation
NCT07379827 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Adverse-effect Switch Evaluation
- Lead sponsor
- Bristol-Myers Squibb
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 26, 2026
- Completion date
- June 20, 2028
- Enrollment
- 1,500 (estimated)
- Sites
- 55
Conditions
As the registry lists them; a condition with its own page is linked.